Every page.
One connected site.
Browse research, products, proposed projects, buyer guides, funding routes and the tools that connect them.
About
Accessibility
Atlas
The Karam Atlas
Filter and compare recent cellular-aging research by model, mechanism, geography, publication date, and evidence type.
Compare Atlas records
Compare the models, endpoints, limitations, and source-access levels of up to three research records.
Atlas coverage and limitations
Exact launch coverage, review access levels, date rules, and known gaps in the Karam evidence collection.
Atlas review method
How Karam resolves sources, labels study models, preserves access limits, and separates external evidence from proposed programs.
Recent evidence
The launch collection ordered by first online publication date, through October 15, 2026.
China research view
Human observations, metabolism, and repair questions. Selected 2026 evidence, model distinctions, and primary-source links.
Europe research view
Cell identity, lipid remodeling, and measurement. Selected 2026 evidence, model distinctions, and primary-source links.
India research view
A controlled human biomarker study. Selected 2026 evidence, model distinctions, and primary-source links.
Japan research view
Target engagement alongside a null primary outcome. Selected 2026 evidence, model distinctions, and primary-source links.
South Korea research view
Cell processing and targeted delivery. Selected 2026 evidence, model distinctions, and primary-source links.
United States research view
Reprogramming questions and multimodal measurement. Selected 2026 evidence, model distinctions, and primary-source links.
Regional evidence map
Explore selected research from China, India, South Korea, Japan, Europe, and the United States.
Contact
Founder
Funding
Biotech funding map: grants, investors, loans & credits
Filter a dated directory of biotech R&D funding and support by category and entry gate, with sources, reported amounts and eligibility limitations.
Federal R&D funding and independent biotech challenges
NIA, NSF, ARPA-H and specific contract or challenge routes have different entry gates. Start with a testable technical risk and the live official notice.
International biotech funding & partner routes
India, South Korea, Europe and the United Kingdom have specific ownership, entity and participation requirements. No directly accessible China grant was established in the source map.
Longevity biotech investors & philanthropic routes
Investment, research financing and philanthropy have different ownership and recipient conditions. A published thesis is not an offer to invest in Karam or any particular applicant.
Biotech R&D credits, tax benefits & cost planning
Service credits and tax benefits can affect costs. They are not sales, cannot all pay payroll, and should not be added to unawarded grants as available cash.
State biotech funding: Maryland, Virginia, NC & DC
A location is an eligibility condition, not a keyword. Compare actual operational commitments, award prerequisites and the difference between a grant, an investment and debt.
Gallery
Home
Licensing
Biotech licensing leads & research-tool opportunities
Explore external Stanford, UCSF and NIH research-technology licensing leads, with development questions and clear ownership boundaries.
NCI Start-Up 3.0: a biotech licensing route
NCI’s program offers a structured license route for selected patented technologies. The source map records a $5,000 execution royalty plus agreed patent expe
NIH research-tool & biological-material licensing
NIH’s technology-transfer guidance distinguishes commercial licensing, evaluation and biological-material arrangements. The source map recommends searching f
Stanford cell-aging clocks: licensing lead
Stanford’s technology listing describes machine-learning estimates of cell-specific aging across 43 cell types. The page presents potential aging and disease
UCSF senescent-cell clearance: licensing lead
The UCSF listing describes clearance of senescent cells through activation of an immune response. The source map identifies it as preclinical and lists U.S.
Notebook
Research notebook
Six question-led essays on cell function, identity, measurement, null results, global evidence, and program design.
From a paper to a testable program
A program is a sequence of decisions, not a list of impressive papers.
Function before an age number
A younger-looking measurement is a starting point, not a finish line.
Global evidence. Local context.
Geography broadens discovery; it does not establish efficacy.
Identity is a safety endpoint
An energetic cell doing the wrong job is not the desired result.
Mechanics without magic
A physical mechanism still needs careful controls.
Why null results belong on the front page
An informative negative result can improve the next experiment.
Partners
Privacy
Products
Cellular-aging research products & services
Explore 18 proposed Karam research scopes, from scientific due diligence and omics analysis to partner studies, evidence software and licensing support.
Cellular-aging research intelligence for teams
A maintained evidence collection around the question your team keeps asking. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular-aging assay & analysis benchmark consortium
Compare methods under one declared set of rules. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular senescence & cell-state assay study planning
Multiple readouts. A defined model. An interpretable result. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular-aging image & omics interpretation software
Developing a better way to tell useful change from misleading signal. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
CRISPR screen analysis & independent interpretation
A ranked hit is a lead. Make the evidence behind it inspectable. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Biotech CRO subcontract analysis & reporting support
A discrete work package that fits the prime contract. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Aging & omics data analysis review
Find out what your existing data can actually support. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular-aging evidence datasets & API licensing
Structured research records with a documented right to use them. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular-aging research & scientific due diligence
One question. A source trail. A decision you can explain. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Biotech licensing landscape & scientific asset diligence
Find the asset. Inspect the evidence. Separate the rights questions. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Private biotech research portal development
Your evidence, tools and exports in one purpose-built workspace. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular-aging reference datasets, controls & assay bundles
A useful benchmark begins with material you can trust and use. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular-aging evidence appraisal workshops
Build a shared standard for interpreting a result. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Longevity research monitoring & material-change briefs
Know what changed—not just what was published. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Skin-aging & cosmetic ingredient research evidence
Connect the ingredient question to the evidence it actually needs. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular-aging sponsored research & co-development
Fund a defined question—not an undefined promise. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Cellular-aging study design & laboratory coordination
A defined experiment, a comparable lab scope and a usable handover. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Transparent research-tool sponsorship opportunities
Reach a relevant audience without buying its conclusions. Explore deliverables, proposed budget, readiness requirements and how to scope a research engagement.
Programs
Research programs
Eight proposed Karam research directions, with functional questions, evidence gaps, and explicit stage labels.
Cell identity & restoration
Can an aged cell regain function without losing its specialized identity?
Cell mechanics
Can controlled physical processing restore useful function to deteriorated cultured cells?
Measurement & evidence
What combination of measurements would justify saying that a cell or tissue functions better?
Microbiome signals
Which microbial signals have a causal, reproducible effect on a defined aging-related function?
Mitochondrial resilience
Which changes in energy metabolism matter to the work that an aging tissue must perform?
Repair & replacement
When is it more realistic to restore an existing cell than to create a replacement population?
Senescence precision
How do we identify persistent harmful states without treating every nondividing cell as a problem?
Targeted delivery
Can a restorative intervention reach a chosen tissue without unacceptable activity elsewhere?
Projects
Cellular-aging research projects & collaboration briefs
Explore proposed Karam projects in cell-state software, senescence panels, skin evidence, CRISPR interpretation, aging clocks and research-tool licensing.
Cell-aging clock generalization research project
Does a cell-aging model remain useful in the intended research setting when the donor, batch, laboratory or disease context changes? Read the proposed scope, decision gates and partner needs; no completed result is claimed.
Cell-state analysis software validation project
Can a context-aware analysis system reduce misleading cellular-aging conclusions compared with existing methods and simpler baselines? Read the proposed scope, decision gates and partner needs; no completed result is claimed.
CRISPR screen interpretation & cell-state research project
Can existing perturbation-screen results be linked to reproducible cellular-state outcomes rather than a hit ranking alone? Read the proposed scope, decision gates and partner needs; no completed result is claimed.
Cellular-aging evidence intelligence pilot project
Can a narrow, maintained evidence collection change a repeated research decision enough that a team chooses to keep paying for it? Read the proposed scope, decision gates and partner needs; no completed result is claimed.
Mechanical cell reactivation evidence project
What independent evidence would be needed to decide whether a mechanical cell-processing result is relevant to a cell-manufacturing workflow? Read the proposed scope, decision gates and partner needs; no completed result is claimed.
Biotech research-tool licensing evaluation project
Would a narrowly scoped license produce a useful research product more credibly than an independent build? Read the proposed scope, decision gates and partner needs; no completed result is claimed.
Cellular senescence panel validation project
Can an agreed set of senescence, viability and functional readouts produce a more interpretable comparison than a marker considered alone? Read the proposed scope, decision gates and partner needs; no completed result is claimed.
Skin-aging ingredient evidence development project
What evidence would change the next development decision for one ingredient, and what would still be missing for a proposed consumer claim? Read the proposed scope, decision gates and partner needs; no completed result is claimed.
Reading-List
Research
Research library
Fifteen recent cellular-health and aging evidence briefs with primary sources, model distinctions, limitations, and review-access labels.
A membrane lipid connects to muscle function
Cardiolipin metabolism, mitochondrial function, and muscle phenotype. Source-linked brief with model and limitations.
Senescence is not one uniform cell state
Cell morphology, transcriptional patterns, and treatment-response profiles. Source-linked brief with model and limitations.
An early human signal, reported by the sponsor
Early safety observations and exploratory visual-function measures. Source-linked brief with model and limitations.
A human biomarker signal from India
Leukocyte telomere measurements, telomerase activity, and gene expression. Source-linked brief with model and limitations.
Target engagement is not the same as benefit
Blood NAD metabolites; hearing and physical-performance outcomes. Source-linked brief with model and limitations.
The chemistry of membranes—not just the amount of fat
Lipid-chain composition; worm lifespan; human genetic associations. Source-linked brief with model and limitations.
Can mechanics restore cultured-cell function?
Proliferation, identity markers, stress readouts, and preclinical repair. Source-linked brief with model and limitations.
One microbe. One metabolite. Several questions.
Human abundance associations; mouse intestinal, inflammatory, and functional outcomes. Source-linked brief with model and limitations.
A younger molecular state—after an identity change
Epigenetic age measures and acquisition of neural stem-cell identity. Source-linked brief with model and limitations.
Repair depends on the tissue’s metabolic context
Acute liver injury, metabolic regulation, and regenerative response. Source-linked brief with model and limitations.
Seeing cell states with more than one measurement
Spatial vibrational signatures, transcriptomic states, and senescence-associated tissue patterns. Source-linked brief with model and limitations.
When a younger clock may track disease recovery
Proteomic aging-clock estimates in previously collected clinical samples. Source-linked brief with model and limitations.
Protecting the blood-forming system
Stem-cell stress, function, lipid remodeling, and mouse immune balance. Source-linked brief with model and limitations.
A different route to cellular reprogramming
Cell-state signatures; senescence-associated features; mouse frailty and survival. Source-linked brief with model and limitations.
Temporary instructions. A specific tissue.
Regeneration and recovery after experimental acute liver injury. Source-linked brief with model and limitations.
Resources
Biotech research buyer guides & source resources
Practical guides to assay costs, study design, CRISPR analysis, scientific diligence, research claims, service procurement and funding readiness.
How to scope an aging-biomarker research study
Define a research question, model, endpoints, quality controls and data handover before commissioning a cellular-aging study.
Biotech research funding readiness checklist
Prepare a technical question, eligible entity, qualified team, data rights, registrations, budget and milestones before pursuing a biotech R&D application.
Biotech licensing due diligence: from listing to decision
Separate scientific evidence, asset availability, development cost, patent questions and commercial-use rights when evaluating a research technology.
How to compare biotech research-service proposals
Compare evidence reviews, data analysis and outsourced study proposals using scope, reviewer qualifications, acceptance criteria and usable rights.
What does a cellular senescence study cost?
Compare published assay cost anchors with the complete scope of a cellular senescence research study: controls, repeats, analysis and data rights.
CRISPR screen analysis: a buyer’s review checklist
A nonclinical scoping checklist for CRISPR screen provenance, data QC, hit robustness, confounders and independent follow-up evidence.
Research biomarkers are not automatically clinical tests
Understand why research-use labels, molecular-age changes and preclinical findings do not automatically establish clinical utility or consumer claims.
Commercial research source register
Inspect 59 original sources behind Karam’s commercial map, including research-service costs, funding routes, licensing leads and policy references.
Roadmap
Science
Scientific questions
Twelve mechanisms and measurement questions connecting Karam’s proposed programs to the recent evidence library.
Biological clocks research guide
A model output is a measurement—not a verdict. A question-led guide to recent source-linked evidence.
Cell identity research guide
What must stay the same when a cell becomes more functional? A question-led guide to recent source-linked evidence.
Cell mechanics research guide
Physical organization as a research variable. A question-led guide to recent source-linked evidence.
Lipid metabolism research guide
Composition and remodeling deserve separate attention. A question-led guide to recent source-linked evidence.
Microbiome research guide
Resolve the causal chain, not the marketing category. A question-led guide to recent source-linked evidence.
Mitochondria research guide
Connect the energy readout to what a tissue does. A question-led guide to recent source-linked evidence.
Multimodal measurement research guide
Look for agreement, but investigate disagreement. A question-led guide to recent source-linked evidence.
RNA regulation research guide
Changing the instructions a cell reads. A question-led guide to recent source-linked evidence.
Senescence research guide
A context problem before it is a treatment target. A question-led guide to recent source-linked evidence.
Targeted delivery research guide
Place and duration are part of the mechanism. A question-led guide to recent source-linked evidence.
Telomeres research guide
A cellular measurement, not an age-reversal percentage. A question-led guide to recent source-linked evidence.
Tissue repair research guide
Recovery from injury is not identical to reversing aging. A question-led guide to recent source-linked evidence.
Scope
Search
Sitemap
Solutions
Research support for biotech teams, investors & laboratories
Find a research workflow for biotech startups, ingredient developers, scientific investors, laboratories and CROs.
Research support for biotech startups
Choose the next experiment before spending on it. Explore proposed research scopes, required inputs and acceptance questions for biotech startups.
Scientific analysis & evidence support for CROs
One accountable work package inside your delivery. Explore proposed research scopes, required inputs and acceptance questions for cros.
Research evidence for cosmetic & ingredient developers
Separate biological activity from the claim you want to make. Explore proposed research scopes, required inputs and acceptance questions for ingredient developers.
Scientific due diligence for longevity investors
Understand the risk behind the headline. Explore proposed research scopes, required inputs and acceptance questions for investors.
Research data review for academic & independent laboratories
Make the analysis easier to inspect and reuse. Explore proposed research scopes, required inputs and acceptance questions for research laboratories.
Standards
Tools
Research tools
Fourteen working research and planning tools, including effect sizes, sample-size sketches, reproducibility checks, project briefs and study budgets.
Dilution arithmetic
Check a simple laboratory-reagent dilution with explicit units and a final-volume constraint.
Population doubling time
Estimate growth over an interval using a simple exponential model and two cell-count observations.
Effect-size workbench
Calculate pooled standard deviation, Cohen’s d, and small-sample-corrected Hedges’ g for two independent groups.
Evidence completeness check
Document what a research record reports—and what you still need to retrieve.
Microscopy scale check
Convert a pixel measurement using a known scale bar in the same image.
Multiple-testing workbench
Apply the Benjamini–Hochberg step-up adjustment to a list of p-values.
Paired change analysis
Compare matched before-and-after values without treating the pairs as independent groups.
Biotech research project scope builder
Build and download a nonconfidential brief for evidence review, data analysis, partner studies or research software. No sign-up; sending is a separate action.
Replicate precision
Inspect the mean, sample standard deviation, standard error, and coefficient of variation of a numeric series.
Research brief builder
Turn a research question into an editable, downloadable brief. All text stays in this browser unless you choose to share it.
Sample-size sketch
Explore an approximate per-group sample size for a two-sided, balanced comparison of two independent means.
Cellular-aging study budget calculator
Calculate an illustrative research budget from sample counts, per-determination lab costs, analysis, management and contingency. Transparent, local arithmetic.
Study comparator
Compare up to three Atlas records side by side without collapsing different models into one score.
Translation gap mapper
Generate the next evidence questions for a selected study model and outcome.
Ventures
CRISPR expansion
Research services, programs, proposed projects, field guides, tools and source-linked briefs.